No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.

University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?

Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
Find out more in a Simmaron Research Foundation sponsored blog:


Like the blog you're reading? Don't miss another one.

Get the most in-depth information available on the latest ME/CFS and FM treatment and research findings by registering for Health Rising's free  ME/CFS and Fibromyalgia blog here.

Stay on Top of the News!

Subscribe To Health Rising’s Free Information on Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia (FM), Long COVID and Related Diseases.

Thank you for signing up!

Pin It on Pinterest

Share This